Global employer-sponsored medical trend has remained in double digits in many markets, with Latin America among the highest-inflation regions in benefit planning surveys.[1][2]
For IPMI carriers, 2026 is about managing two simultaneous realities: high routine inflation and a continued rise in high-cost severity claims, especially oncology and complex inpatient episodes.[3]
Medical Trend in the Americas: The Macro Signal
WTW and Aon trend publications continue to show elevated medical costs globally, with sustained pressure from utilization recovery, provider pricing, and pharmaceutical spend.[1][2] Mercer and other employer surveys report similar inflation dynamics in Latin American private healthcare.[4]
Top IPMI Claims Categories by Cost
- Oncology: biologics, immunotherapy, and longer treatment duration remain primary severity drivers.[5]
- Cardiovascular and neuro: high-cost acute admissions and interventions.[3]
- Orthopedic and trauma: imported implant pricing and rehab episodes.[6]
- Maternity/neonatal: NICU episodes materially skew claim tails.[7]
Frequency vs. Severity: What Is Actually Changing
Across international books, frequency has normalized post-pandemic, but average claim size remains elevated due to case mix intensity and tariff inflation in private hospitals.[3][8] In simple terms: more predictable volume, less predictable tail risk.
Emerging Cost Drivers Carriers Must Price In
- Specialty pharmacy and oncology pathway expansion.[5]
- Out-of-network tertiary referrals into USD-priced centers.[6]
- Mental health and chronic comorbidity utilization growth.[4]
- Currency volatility in cross-border reimbursement.[9]
Actionable 2026 Playbook for IPMI Carriers
| Lever | What to Implement | Expected Impact |
|---|---|---|
| Network steering | Pre-negotiate regional COEs and package rates | Lower admission unit cost |
| Oncology governance | Protocol + second-opinion + pathway checks | Severity containment |
| Case management | Early complex-case flagging at first admission | Reduced avoidable readmissions |
| Benefit design | Tiered co-pay and referral controls | Utilization discipline |
Carriers running these levers with near-real-time claims analytics outperform those managing only at renewal cycle.[8][10]
The Bottom Line
IPMI claims inflation in the Americas is now a structural challenge, not a temporary spike. Winning carriers will combine medical trend intelligence with regional provider strategy and proactive case management. To operationalize this approach, visit MDabroad or contact MDabroad.
References
- WTW. Global Medical Trends Survey. 2025. URL
- Aon. Global Medical Trend Rates Report. 2025. URL
- Allianz Partners. Global Health and Assistance Insights. 2024. URL
- Mercer Marsh Benefits. Health Trends Report. 2024. URL
- IQVIA Institute. Global Use of Medicines. 2024. URL
- Global Health Intelligence. Hospital Capacity in Latin America. 2024. URL
- WHO/PAHO. Maternal and Neonatal Health in the Americas. 2024. URL
- Deloitte. 2025 Global Health Care Outlook. 2025. URL
- IMF. Regional Economic Outlook: Western Hemisphere. 2025. URL
- McKinsey. Global Insurance Report. 2025. URL